180 related articles for article (PubMed ID: 27376011)
1. CXCL13 chemokine as a promising biomarker to diagnose neurosyphilis in HIV-negative patients.
Zeng YL; Lin YQ; Zhang NN; Zou CN; Zhang HL; Peng F; Liu ZJ; Zheng WH; Yan JH; Liu LL
Springerplus; 2016; 5(1):743. PubMed ID: 27376011
[TBL] [Abstract][Full Text] [Related]
2. CXCL13 as a cerebrospinal fluid marker for neurosyphilis in HIV-infected patients with syphilis.
Marra CM; Tantalo LC; Sahi SK; Maxwell CL; Lukehart SA
Sex Transm Dis; 2010 May; 37(5):283-7. PubMed ID: 20393380
[TBL] [Abstract][Full Text] [Related]
3. Analysis of
Yang L; Fu Y; Li S; Liu C; Liu D
Infect Drug Resist; 2022; 15():7791-7798. PubMed ID: 36600952
[TBL] [Abstract][Full Text] [Related]
4. Value of CXCL13 in diagnosing asymptomatic neurosyphilis in HIV-infected patients.
Hu R; Lu C; Lu S; Hu Y; Ma H; Lai W; Zhu G; Feng P; Lu R; Li Y
Int J STD AIDS; 2016 Feb; 27(2):141-6. PubMed ID: 25769888
[TBL] [Abstract][Full Text] [Related]
5. CXCL13 and TH1/Th2 cytokines in the serum and cerebrospinal fluid of neurosyphilis patients.
Yan Y; Wang J; Qu B; Zhang Y; Wei Y; Liu H; Wu C
Medicine (Baltimore); 2017 Nov; 96(47):e8850. PubMed ID: 29381995
[TBL] [Abstract][Full Text] [Related]
6. Cerebrospinal fluid CXCL13 concentration for diagnosis and monitoring of neurosyphilis in people with HIV.
Carvalho RS; Rangel IC; Soane MM; Bacarov NBS; Herbst V; Ferry FRA
AIDS; 2024 Apr; 38(5):657-668. PubMed ID: 38079581
[TBL] [Abstract][Full Text] [Related]
7. Has CXCL13 an added value in diagnosis of neurosyphilis?
Mothapo KM; Verbeek MM; van der Velden LB; Ang CW; Koopmans PP; van der Ven A; Stelma F
J Clin Microbiol; 2015 May; 53(5):1693-6. PubMed ID: 25788544
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic role of CXCL13 and CSF serology in patients with neurosyphilis.
Li D; Huang X; Shi M; Luo L; Tao C
Sex Transm Infect; 2021 Nov; 97(7):485-489. PubMed ID: 33436504
[TBL] [Abstract][Full Text] [Related]
9. Alternatives to the Cerebrospinal Fluid Venereal Disease Research Laboratory Test for Neurosyphilis Diagnosis.
Marra CM
Sex Transm Dis; 2021 Aug; 48(8S):S54-S57. PubMed ID: 33967236
[TBL] [Abstract][Full Text] [Related]
10. Chemokine Ligand 13 (CXCL13) in Neuroborreliosis and Neurosyphilis as Selected Spirochetal Neurological Diseases: A Review of Its Diagnostic Significance.
Gudowska-Sawczuk M; Mroczko B
Int J Mol Sci; 2020 Apr; 21(8):. PubMed ID: 32331231
[TBL] [Abstract][Full Text] [Related]
11. Aberrant Humoral Immune Responses in Neurosyphilis: CXCL13/CXCR5 Play a Pivotal Role for B-Cell Recruitment to the Cerebrospinal Fluid.
Yu Q; Cheng Y; Wang Y; Wang C; Lu H; Guan Z; Huang J; Gong W; Shi M; Ni L; Wu J; Peng R; Zhou P
J Infect Dis; 2017 Sep; 216(5):534-544. PubMed ID: 28931218
[TBL] [Abstract][Full Text] [Related]
12. Invasion of the central nervous system by Treponema pallidum: implications for diagnosis and treatment.
Lukehart SA; Hook EW; Baker-Zander SA; Collier AC; Critchlow CW; Handsfield HH
Ann Intern Med; 1988 Dec; 109(11):855-62. PubMed ID: 3056164
[TBL] [Abstract][Full Text] [Related]
13. Neurosyphilis Increases Human Immunodeficiency Virus (HIV)-associated Central Nervous System Inflammation but Does Not Explain Cognitive Impairment in HIV-infected Individuals With Syphilis.
Ho EL; Maxwell CL; Dunaway SB; Sahi SK; Tantalo LC; Lukehart SA; Marra CM
Clin Infect Dis; 2017 Sep; 65(6):943-948. PubMed ID: 28525592
[TBL] [Abstract][Full Text] [Related]
14. CXCL13, CXCL10 and CXCL8 as Potential Biomarkers for the Diagnosis of Neurosyphilis Patients.
Wang C; Wu K; Yu Q; Zhang S; Gao Z; Liu Y; Ni L; Cheng Y; Guan Z; Shi M; Lu H; Lou Y; Zhou P
Sci Rep; 2016 Sep; 6():33569. PubMed ID: 27650493
[TBL] [Abstract][Full Text] [Related]
15. Multicentric evaluation of a specific intrathecal anti-
Alberto C; Lambeng N; Deffert C; Breville G; Gayet-Ageron A; Lalive P; Calmy A; Coste A; Papadimitriou-Olivgeris M; Braun D; Lienhard R; Bosshard PP; Fontao L; Toutous Trellu L
Sex Transm Infect; 2024 Feb; 100(2):63-69. PubMed ID: 38071543
[TBL] [Abstract][Full Text] [Related]
16. Detection of Treponema pallidum Sp. Pallidum DNA in Cerebrospinal Fluid (CSF) by Two PCR Techniques.
Castro R; Águas MJ; Batista T; Araújo C; Mansinho K; Pereira Fda L
J Clin Lab Anal; 2016 Sep; 30(5):628-32. PubMed ID: 26892231
[TBL] [Abstract][Full Text] [Related]
17. CXCL13 concentration in latent syphilis patients with treatment failure.
Zhang Y; Wang J; Wei Y; Liu H; Wu C; Qu B; Yan Y
Open Med (Wars); 2020; 15(1):635-643. PubMed ID: 33336020
[TBL] [Abstract][Full Text] [Related]
18. Syphilis and neurosyphilis: HIV-coinfection and value of diagnostic parameters in cerebrospinal fluid.
Merins V; Hahn K
Eur J Med Res; 2015 Oct; 20():81. PubMed ID: 26445822
[TBL] [Abstract][Full Text] [Related]
19. Cerebrospinal fluid CXCL13 concentration for diagnosis of neurosyphilis: a systematic review and meta-analysis.
Du FZ; Zhang X; Zheng XL; Zhang RL; Wang QQ
BMJ Open; 2024 May; 14(5):e078527. PubMed ID: 38821573
[TBL] [Abstract][Full Text] [Related]
20. Frequency of Treponema pallidum invasion into cerebrospinal fluid in primary or secondary early-stage syphilis.
Hagihara M; Yamagishi Y; Kato H; Shibata Y; Shiota A; Sakanashi D; Suematsu H; Watanabe H; Asai N; Koizumi Y; Furui T; Takahashi S; Izumi K; Mikamo H
J Infect Chemother; 2018 May; 24(5):404-406. PubMed ID: 29229275
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]